Drug intelligence / Profile preview

TriBsyn

Development stage
Unknown
Lead developer
Natural Alternatives International
Modality
Small Molecules
Administration
Oral
01

Overview

TriBsyn is a proprietary, patent-pending carnosine booster formulated to significantly enhance the bioavailability and absorption of beta-alanine while eliminating the common side effect of paresthesia (tingling) associated with conventional beta-alanine supplementation. Developed using CarnoSyn beta-alanine and Hydro Oleo technology, TriBsyn enables efficacious dosing at much lower volumes—achieving over four times higher plasma beta-alanine levels compared to standard formulations. This allows for improved muscle function, cognitive performance, and healthy aging support, particularly benefiting older adults, individuals on plant-based diets, and users of GLP-1 receptor agonists who may be at risk for muscle mass loss. Clinical trials have demonstrated that a 400 mg dose of TriBsyn outperforms both equivalent and higher doses of conventional beta-alanine in terms of bioavailability while eliminating paresthesia[1][3][4][5][6][7].

Brand names
TriBsyn
Other names
TriBsyn Powder
02

Targets

CARNS1 (Carnosine synthase 1)

Beyond the preview

Go deeper on TriBsyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TriBsyn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call